// App-Quantinova.ai

1364 : Novel 4-(pyrimidin-2-yl)morpholines targeting the colchicine-binding site of tubulin

Researchers

Presenter

  • Alexander M. Sele

Principal Investigators

  • Denise Rageot

  • Thomas Bohnacker

  • Florent Beaufils

  • Andrea E. Prota

  • Michel O. Steinmetz

  • Matthias P. Wymann

Medical Centers

  • University Hospital Basel, Basel, Switzerland

  • Paul Scherrer Institute, Villigen, Switzerland.

Locations

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Colchicine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved